Patents by Inventor Kathryn Bronstein

Kathryn Bronstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of treprostinil to treat and prevent ischemic lesions
    Patent number: 8765813
    Abstract: The present disclosure relates to novel methods for using treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The disclosure also relates to kits for treatment and/or prevention of ischemic lesions, which include an effective amount of treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: July 1, 2014
    Assignee: United Therapeutics Corporation
    Inventors: Michael Wade, Roger Jeffs, Robert Roscigno, Deborah Strootman, Kathryn Bronstein
  • Use of treprostinil to improve kidney functions
    Patent number: 7199157
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for improving kidney functions, such as urine output, and treating symptoms associated with kidney malfunction or failure. The invention also relates to kits for the improvement of kidney functions and the treatment of symptoms associated with kidney malfunction or failure, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: April 3, 2007
    Assignee: United Therapeutics Corporation
    Inventors: Michael Wade, Roger Andrew Jeffs, Kathryn Bronstein, Deborah Strootman
  • Use of treprostinil to improve kidney functions
    Publication number: 20050165110
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for improving kidney functions, such as urine output, and treating symptoms associated with kidney malfunction or failure. The invention also relates to kits for the improvement of kidney functions and the treatment of symptoms associated with kidney malfunction or failure, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 16, 2004
    Publication date: July 28, 2005
    Inventors: Michael Wade, Roger Andrew Jeffs, Kathryn Bronstein, Deborah Strootman
  • Use of treprostinil to treat and prevent ischemic lesions
    Publication number: 20050165111
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 16, 2004
    Publication date: July 28, 2005
    Inventors: Michael Wade, Roger Jeffs, Robert Roscigno, Deborah Strootman, Kathryn Bronstein